Graduated from the School of Humanities and Social Sciences of the Autonomous University of Baja California (UABC) in Tijuana, Mexico. Since 2009 he has carried out community intervention with different populations in vulnerable contexts from the area of public health and human rights.

"La Zona" in Tijuana, represents a critical harm reduction intervention in one of Mexico’s most challenging environments for drug use. Due to its proximity to the
U.S. border, drug consumption and trafficking patterns in Mexican border cities, such as Tijuana, have resulted in higher levels of heroin injection compared to the rest of
the country.

Many of these initiatives were made possible through the support of the Global Fund to Fight AIDS, Tuberculosis, and Malaria and later on by the
support of the Federal Commission to Prevent and Control HIV AIDS (CENSIDA).

In response to those public health challenges driven by drug use at the border, harm reduction initiatives emerged, in cities like Ciudad Juárez, where the first needle
exchange program was implemented in the late 1980s. More recently, in 2019, Mexicali established "La Sala" the first safe consumptionsite in the Global South.

In Baja California, PrevenCasa has been providing harm reduction services since the late 1990s and officially became a community organization in 2007 to
address the HIV and HCV epidemics among people who inject drugs. Tijuana, a key transit point for drug trafficking to the U.S., is home to vulnerable populations,
including deported individuals, sex workers, and a significant number of homeles populations of
people who inject drugs. Operating as a harm reduction community clinic, PrevenCasa offers basic health services, training for medical professionals,
and partnerships with researchers to document evidence-based interventions.

"La Zona," offers a "safe space" for women who use drugs, providing areas for both injection and smoking, along with rest and recreation facilities supported by
healthcare personnel. Women who inject drugs face a heightened risk of negative health outcomes, including HIV, HCV, overdoses, and sexually transmitted
diseases, and also experience structural barriers to accessing healthcare and overdose prevention services.